Design, synthesis and evaluations of spiro-fused benzoxaborin derivatives as novel boron-containing compounds

Chem Biol Drug Des. 2019 May;93(5):657-665. doi: 10.1111/cbdd.13496. Epub 2019 Mar 20.

Abstract

Drug design using boron-containing heterocycles has attracted a great deal of attention because these compounds are believed to possess high biological activity. However, information on the synthetic methodology and pharmacokinetic profiling of boron-containing compounds is limited. In this study, we provide a new synthetic route for preparation of spiro-fused benzoxaborin derivatives and investigate their in vitro pharmacokinetic properties. Our efforts led to the successful construction of a chemical library of spiro-fused benzoxaborin derivatives with appropriate physicochemical and in vitro pharmacokinetic properties for oral drugs. These results indicate that the synthesized boron-containing compounds are therefore eligible for classification in a novel chemical library.

Keywords: benzoxaborin; boron-containing heterocycles; chemical library; oxindole; spiro-fused compounds.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Boron / chemistry*
  • Cell Membrane Permeability / drug effects
  • Drug Design*
  • Half-Life
  • Humans
  • Indoles / chemical synthesis*
  • Indoles / pharmacokinetics
  • Indoles / pharmacology
  • Microsomes, Liver / metabolism
  • Spiro Compounds / chemistry*

Substances

  • Indoles
  • Spiro Compounds
  • Boron